Why the study?
Leukostasis rarely leads to myocardial ischemia, and optimal treatment strategies for patients with acute coronary syndrome precipitated by CML blast crisis need illustration.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
This case highlights that CML blast crisis can precipitate NSTEMI due to hyperviscosity, which can be successfully managed with a combination of cytoreductive therapy and standard ACS medical management following coronary angiography.
Acute coronary syndrome (ACS) is a condition that develops from reduced blood flow and oxygen delivery through the coronary arteries which leads to cardiac ischemia. In the case presented here, the patient’s ACS was precipitated by his underlying condition of chronic myelogenous leukemia (CML). Several complications can arise in patients with CML, one of them being blast crisis. Blast crisis is defined by 20% or greater blasts in the peripheral blood, or extramedullary proliferation of blasts. There is a known phenomenon of blood hyperviscosity that can develop in such patients which can lead to complications of stroke-like symptoms, congestive heart failure, and acute respiratory failure. In such cases, leukostasis rarely leads to myocardial ischemia. We present a challenging case of a patient with an acute coronary syndrome (ACS) precipitated by a blast crisis. This case highlights a potentially life-threatening cardiac complication of CML in patients with coronary artery disease and aimed to provide an optimal treatment strategy to improve outcomes.
No takes yet. Share an insight, caveat, or question.
Nuthulaganti et al. (2021) conducted a case report in NSTEMI and CML blast crisis (n=1). Hydroxyurea and standard ACS medical therapy was evaluated on Resolution of ischemia and hyperleukocytosis.
Synapse has enriched 10 related papers. Consider them for comparative context: